EGETIS THERAPEUTICS AB NPV earnings per share and revenue

0ABW earnings per share for the last quarter are -0.28 SEK whereas the estimation was -0.30 SEK which accounts for 5.52% surprise. Company revenue for the same period amounts to 9.40 M SEK despite the estimated figure of 15.65 M SEK. Estimated earnings per share for the next quarter are -0.26 SEK, and revenue is expected to reach 15.30 M SEK. Also watch annual changes over time to get a bigger picture of 0ABW earnings per share and revenue dynamics.